Error processing SSI file
Termination of the Emergency Use Authorization (EUA) of Medical Products and Devices
Site last updated June 24, 2010 10:00 AM ETPer the FDA-issued advance notice letters listed below, the declaration of Public Health Emergency determination for 2009 H1N1 Influenza expired on June 23, 2010.
- Termination of Declarations of Emergency Justifying EUA of Certain Antiviral Drugs: Tamiflu (oseltamivir phosphate), Relenza (zanamivir), and Peramivir
- Termination of Declaration of Emergency Justifying the Authorization of Emergency Use of Certain Personal Respiratory Protection Devices
- Termination of Declaration of Emergency Justifying EUA of Certain In Vitro Diagnostic Tests
Information regarding Termination and Disposition of CDC-requested and FDA-issued EUA Products:
Antiviral Drugs:
- Relenza (zanamivir) and Tamiflu (oseltamivir)
- Disposition Letter for Relenza and Tamiflu
- Attachment 1 to the Disposition Letter for Relenza and Tamiflu: Questions and Answers Regarding Termination of the Emergency Use Authorizations (EUAs) for Tamiflu (oseltamivir) and Relenza (zanamivir)
- Attachment 2 to the Disposition Letter for Relenza and Tamiflu:Update regarding Stockpiled Antivirals at or Nearing Expiration
- Peramivir IV
Devices:
- N95 Respirators
For questions regarding EUAs, contact: EUA.OCET@fda.hhs.gov
Get email updates
To receive weekly email updates about this site, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO